Lijing Zhang Selected Research

Lijing Zhang Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 09/2013
4	Inflammation (Inflammations) 01/2022 - 01/2015
4	Cognitive Dysfunction 01/2022 - 01/2018
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2014
4	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 09/2013
3	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020 - 01/2018
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 09/2013
2	Obesity 01/2022 - 01/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 12/2020
2	Osteoarthritis 01/2022 - 03/2016
2	Body Weight (Weight, Body) 01/2021 - 01/2015
2	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2019
2	Infarction (Infarctions) 01/2020 - 01/2019
2	Pancreatitis 01/2020 - 06/2015
2	Breast Neoplasms (Breast Cancer) 09/2019 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 01/2019 - 09/2016
2	Amnesia (Dissociative Amnesia) 06/2018 - 01/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 01/2015
2	Pain (Aches) 01/2015 - 01/2015
1	Heart Failure 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	COVID-19 01/2022
1	Rheumatoid Arthritis 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Embolism (Embolus) 01/2022
1	Calciphylaxis 12/2021
1	Coronary Disease (Coronary Heart Disease) 03/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Ischemia 01/2021
1	Necrosis 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Dyspnea (Shortness of Breath) 01/2021
1	Lymphatic Metastasis 12/2020

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 11/2020 - 06/2015
7	Pharmaceutical PreparationsIBA 01/2022 - 01/2015
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
4	AntioxidantsIBA 01/2022 - 03/2016
3	Liposomes (Liposome)IBA 01/2020 - 01/2017
3	Peptides (Polypeptides)IBA 09/2019 - 01/2019
3	MicroRNAs (MicroRNA)IBA 05/2014 - 09/2013
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 05/2020
2	Therapeutic UsesIBA 01/2022 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 06/2007
2	IsoflavonesIBA 11/2020 - 06/2018
2	Neuroprotective AgentsIBA 11/2020 - 06/2018
2	Cholinergic Agents (Cholinergics)IBA 11/2020 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2020 - 09/2013
2	GenisteinIBA 04/2020 - 01/2018
2	TIE-2 Receptor (Receptor, TIE 2)IBA 09/2019 - 01/2019
2	AngiopoietinsIBA 09/2019 - 01/2019
2	CateninsIBA 01/2019 - 01/2019
2	Scopolamine (Hyoscine)FDA Link 06/2018 - 01/2018
2	Chloroquine (Aralen)FDA LinkGeneric 01/2017 - 06/2015
2	LipidsIBA 01/2017 - 01/2015
1	Insulin (Novolin)FDA Link 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Long Noncoding RNAIBA 01/2022
1	GoldIBA 01/2022
1	LeptinIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	GlycolipidsIBA 01/2022
1	dictamnineIBA 01/2022
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 01/2022
1	BerberineIBA 01/2022
1	Gefitinib (Iressa)FDA Link 01/2022
1	InterleukinsIBA 01/2022
1	Flurbiprofen (Froben)FDA LinkGeneric 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	osimertinibIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Dacarbazine (DIC)FDA LinkGeneric 01/2022
1	CalciumIBA 12/2021
1	Circulating Tumor DNAIBA 12/2021
1	5-HT1B Serotonin ReceptorIBA 01/2021
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2021
1	Tolvaptan FDA Link 01/2021
1	Lipase (Acid Lipase)FDA Link 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Serotonin ReceptorsIBA 01/2021
1	Nonesterified Fatty Acids (NEFA)IBA 01/2021
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2021
1	Insulin Receptor Substrate ProteinsIBA 01/2021

Therapy/Procedure

13	Therapeutics 01/2022 - 09/2013
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2019
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 01/2015
2	Immunotherapy 12/2020 - 02/2019
2	Percutaneous Coronary Intervention 12/2020 - 01/2020
1	Thrombolytic Therapy 01/2022
1	Transplantation 01/2022
1	Renal Dialysis (Hemodialysis) 12/2021
1	Secondary Prevention 03/2021
1	Investigational Therapies (Experimental Therapy) 01/2021